Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.

NCT06899633 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06899633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06899633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
May 15, 2025
Completion date
February 28, 2027
Enrollment
509 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

description of methods and approaches to the treatment of patients with sle in the republic of kazakhstan, description of sle activity in patients in routine practice in the republic of kazakhstan, description of the course of sle in patients in the republic of kazakhstan